OHSU
Categories | Inventors

HPa1 Monoclonal Antibody Supernatant from Hybridoma DHIC2 2-C12 (alpha cell marker)

 

OHSU # 1038G

Summary:

Technology Overview: The monoclonal antibody HPa1 is derived from the hybridoma DHIC2-2C12. HPa1 selectively reacts with a cell surface module on human pancreatic endocrine cells. This antibody reacts with multiple endocrine cell types.

____________________________________________________________________________

Antibody: HPa1 Supernatant

Hybridoma cell line: DHIC2-2C12

Isotype: Mouse IgM

Species reactivity: Human

Applications: Immunohistochemistry (acetone fixation recommended), Flow cytometry

____________________________________________________________________________

Competitive Environment: No other such antibodies with such specificity are known to exist.

Patent Status: Patent application filed.

Availability: 1mL supernatant aliquot.

For more information, view the PDF version of this summary: HPa1 Antibody Overview

Inventors:

Related Technologies:

  • OHSU # 1038 — Monoclonal Antibodies that React with Cell Surface Molecules on Human Pancreatic Duct Cells, Endocrine (Islet) Cells, Exocrine Cells and Alpha Cells
  • OHSU # 1038A — HPi1 Monoclonal Antibody Supernatant from Hybridoma HIC0 4-F9 (endocrine cell marker)
  • OHSU # 1038B — HPi2 Monoclonal Antibody Supernatant from Hybridoma HIC1 2-B4 (endocrine cell marker)
  • OHSU # 1038D — HPi4 Monoclonal Antibody Supernatant from Hybridoma HIC1 5-F10 (endocrine cell marker)
  • OHSU # 1038E — HPi3 Monoclonal Antibody Supernatant from Hybridoma HIC1 7-H10 (endocrine cell marker)
  • OHSU # 1038H — HPa2 Monoclonal Antibody Supernatant from Hybridoma DHIC2-2B4 (alpha cell marker)
  • OHSU # 1038I — HPx2 Monoclonal Antibody Supernatant from Hybridoma HIC1 1-C10 (exocrine cell marker)
  • OHSU # 1038J — HPd1 Monoclonal Antibody Supernatant from Hybridoma DHIC2 4-A10 (duct cell marker)
  • OHSU # 1038K — HPd2 Monoclonal Antibody Supernatant from Hybridoma DHIC3 5-H10 (duct cell marker)

Categories:

For more information, contact:

Robert Copenhaver
Technology Development Manager
503-494-7809

OptionPrice
(terms)  $60.00
(terms)  $120.00